Analysis Of Income And Expense [Abstract]

ChemoMetec - Filing #1398588

Concept	2021-07-01 to 2022-06-30	2021-07-01 to 2022-06-30	2021-07-01 to 2022-06-30	2020-07-01 to 2021-06-30	2020-07-01 to 2021-06-30	2020-07-01 to 2021-06-30	2020-07-01 to 2021-06-30
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	427,160 DKK	—	—	281,127 DKK	—	—	—
Material income and expense [abstract]
Other finance income	1,883 DKK	—	—	920,000 DKK	—	—	—
Expenses by nature [abstract]
Raw materials and consumables used	55,354 DKK	—	—	37,330 DKK	—	—	—
Classes of employee benefits expense [abstract]
Employee benefits expense	120,060 DKK	—	—	94,273 DKK	—	—	—
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	20,038 DKK	—	—	19,607 DKK	—	—	—
Other expenses, by nature	41,301 DKK	—	—	23,441 DKK	—	—	—
Disclosure of attribution of expenses by nature to their function [text block]	—	—	—	—	—	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	159,943 DKK	22,000 DKK	159,921 DKK	88,330 DKK	10,000 DKK	18,730 DKK	69,610 DKK